http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1106611-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e7022e391363a3cf3486bf3859ce0a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
filingDate 2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a53ede50da61d48b8dbf56c5b0fc02d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64bef6f903eb3c1c61b2aaefd24df0e9
publicationDate 2001-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1106611-A1
titleOfInvention Crystalline or crystallized acid addition salt of losartan and purification method of losartan
abstract The present invention provides a crystalline or crystallized acid addition salt of Losartan useful for obtaining highly pure 2-n-butyl-4-chloro-1-ÄÄ2'-(1H-tetrazol-5-yl)Ä1,1'-biphenylÜ-4-ylÜmethy lÜ-1H-imidazole-5-methanol (Losartan), and a purification method of Losartan that includes production of the crystalline or crystallized acid addition salt.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004066997-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004066997-A2
priorityDate 1999-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9310106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9818787-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9517396-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17986852
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581195
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503925
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15459053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394611
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18318846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18318845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450273274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232293111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232294241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136046515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266664

Total number of triples: 59.